Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON GLENMARK PHARMA BIOCON /
GLENMARK PHARMA
 
P/E (TTM) x 36.5 12.3 297.4% View Chart
P/BV x 4.5 1.6 290.3% View Chart
Dividend Yield % 0.2 0.6 25.1%  

Financials

 BIOCON    GLENMARK PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-22
GLENMARK PHARMA
Mar-21
BIOCON /
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs424573 74.1%   
Low Rs315195 161.2%   
Sales per share (Unadj.) Rs68.2387.8 17.6%  
Earnings per share (Unadj.) Rs8.234.4 23.7%  
Cash flow per share (Unadj.) Rs14.950.1 29.8%  
Dividends per share (Unadj.) Rs0.502.50 20.0%  
Avg Dividend yield %0.10.7 20.8%  
Book value per share (Unadj.) Rs68.5249.6 27.5%  
Shares outstanding (eoy) m1,200.60282.17 425.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.41.0 547.5%   
Avg P/E ratio x45.311.2 405.9%  
P/CF ratio (eoy) x24.77.7 322.9%  
Price / Book Value ratio x5.41.5 350.4%  
Dividend payout %6.17.3 84.4%   
Avg Mkt Cap Rs m443,622108,353 409.4%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80123,437 80.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840109,439 74.8%  
Other income Rs m6,891502 1,372.3%   
Total revenues Rs m88,731109,941 80.7%   
Gross profit Rs m13,82721,289 64.9%  
Depreciation Rs m8,1424,436 183.6%   
Interest Rs m6763,531 19.1%   
Profit before tax Rs m11,90013,825 86.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1154,124 51.3%   
Profit after tax Rs m9,7859,701 100.9%  
Gross profit margin %16.919.5 86.9%  
Effective tax rate %17.829.8 59.6%   
Net profit margin %12.08.9 134.9%  
BALANCE SHEET DATA
Current assets Rs m83,82373,596 113.9%   
Current liabilities Rs m38,28042,010 91.1%   
Net working cap to sales %55.628.9 192.8%  
Current ratio x2.21.8 125.0%  
Inventory Days Days1017 1,517.9%  
Debtors Days Days9286 107.0%  
Net fixed assets Rs m117,18467,093 174.7%   
Share capital Rs m6,003282 2,127.4%   
"Free" reserves Rs m76,28170,148 108.7%   
Net worth Rs m82,28470,430 116.8%   
Long term debt Rs m39,98538,888 102.8%   
Total assets Rs m201,007140,689 142.9%  
Interest coverage x18.64.9 378.5%   
Debt to equity ratio x0.50.6 88.0%  
Sales to assets ratio x0.40.8 52.3%   
Return on assets %5.29.4 55.3%  
Return on equity %11.913.8 86.3%  
Return on capital %10.315.9 64.8%  
Exports to sales %00-   
Imports to sales %7.80-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m6,360NA-   
Fx inflow Rs m8,88535,753 24.9%   
Fx outflow Rs m6,36012,023 52.9%   
Net fx Rs m2,52523,729 10.6%   
CASH FLOW
From Operations Rs m11,76611,312 104.0%  
From Investments Rs m-16,991-6,752 251.6%  
From Financial Activity Rs m2,421-4,418 -54.8%  
Net Cashflow Rs m-2,433278 -874.6%  

Share Holding

Indian Promoters % 39.7 46.7 85.2%  
Foreign collaborators % 20.9 0.0 -  
Indian inst/Mut Fund % 24.0 34.7 69.2%  
FIIs % 16.3 24.2 67.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 53.4 73.8%  
Shareholders   341,016 312,473 109.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    CIPLA    AUROBINDO PHARMA    



Today's Market

Sensex Trades Flat; Energy and Oil and Gas Sector Rally(10:30 am)

Asian share markets were trading on a mixed note this morning. The Nikkei surged 2.4% while the Hang Seng was down by 0.1%. The Shanghai Composite was trading higher by 0.1%.